Duramesh repair versus minimally invasive IPOM for high-risk umbilical hernia
Official title: Duramesh Versus Minimally Invasive Intraperitoneal Onlay Mesh (IPOM) for High-Risk Umbilical Hernia Repairs: A Randomized Controlled Trial
Run by Northwestern University · NCT07881354 · Data updated 2026-11-12
This trial tests whether Duramesh repair can match the pain outcomes of minimally invasive IPOM in adults with high-risk umbilical or ventral hernias.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Northwestern University Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | October 23, 2026 |
| Main results expected | October 2027 |
| Study ends | October 2029 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07881354 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older with symptomatic umbilical hernia (fascial defect ≥1 cm) and at least one high-risk comorbidity (BMI ≥30, active smoker, diabetes, or COPD) undergoing elective repair.
✕Probably not a fit
Patients without high-risk comorbidities or those with large hernias (>6 cm) or other exclusion criteria may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, randomized trial compares two surgical approaches for elective umbilical hernia repair in adults with obesity, diabetes, smoking, or COPD. Participants are randomized after consent to receive either Duramesh suture repair or minimally invasive IPOM, with standardized pre- and postoperative care. The primary outcome is postoperative day 1 pain, with non-inferiority defined as the upper bound of the 95% CI for the pain difference not exceeding 2 points on the NRS; if non-inferiority is shown, superiority is tested. Secondary outcomes include complications, quality of life, return to activity, costs, and hernia recurrence up to 2 years. Most secondary data come from the ACHQC registry, and follow-up includes recurrence or reoperation events as applicable.
Why it matters
Potential benefit: If successful, this approach could reduce pain and improve recovery for high-risk patients undergoing umbilical hernia repair.
How similar studies have gone: Prior work suggests mesh-based repairs reduce recurrence versus sutures, but this specific Duramesh vs IPOM approach in high-risk patients is being tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Symptomatic umbilical hernia with fascial defect ≥1 cm * At least one high-risk comorbidity: BMI ≥30, active smoking, diabetes, or COPD * Undergoing elective repair Exclusion Criteria: * Hernia defect \>6 cm * Urgent or emergent presentation * CDC wound class II-IV * Prior mesh at the umbilicus * Ascites * Pregnancy
Where it's running
-
Northwestern Memorial Hospital
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Nancy Ly, MD
- Email: nancy.ly@nm.org
- Phone: 3126956868
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Epidural vs. opioid-sparing pain control after complex ventral hernia repair
This trial tests whether an epidural for pain relief after transversus abdominis release hernia repair works better than a non‑opioid, abdominal wall numbing injection approach.
-
Risk factors for mesh infection after abdominal wall reconstruction
This study tests which factors put adults at risk for mesh infection after abdominal wall reconstruction using different mesh types.
-
Hernia Sac Flap Coverage of Mesh in Complex Bony-Edged Ventral Hernias
We’re testing whether using the patient’s own hernia sac as a living flap underneath the mesh helps healing after complex ventral hernia repair when part of the edge is bone.
-
Ultrasound-guided EXORA (external oblique and rectus abdominis plane) block for pain and stress in umbilical hernia repair
This trial will test whether adding an ultrasound-guided EXORA block to general anesthesia reduces surgical stress hormones and postoperative pain after elective umbilical hernia repair in adults.
-
AGN-151607-DP to help close the belly wall after open midline ventral hernia repair
This trial tests whether a single intramuscular dose of AGN-151607-DP helps safely close the belly wall in adults having open midline ventral hernia repair.
-
Intensive lifestyle intervention for patients undergoing ventral hernia repair
This study tests if a special program that helps people change unhealthy habits can reduce complications after surgery for ventral hernia repair.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.